FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...
The "Prefilled Syringe Fill Finish Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel ...
The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care Provided by PR Newswire Aug 4, 2025, 10:50:00 AM BD to Invest $35 Million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results